Application
Thiamet G has been used as an O-GlcNAcase inhibitor:to treat human embryonic kidney 293 cells in order to study its effect on Wnt/beta-catenin signallingto treat lytically-replicating producerto incubate mice (C57BL/6) aortic segments to increase global O-GlcNAc levels
Biochem/physiol Actions
Thiamet G is a potent inhibitor of the enzyme O-GlcNAcase (Ki = 21 nM). The compound is orally bioavailable and crosses the blood brain barrier. Thiamet G leads to an increase in O-GlcNAc-modified proteins in cell-based and in vivo assay systems, and reduces levels of phosphorylated Tau protein in rat cortex and hippocampus.
Packaging
5, 25 mg in glass bottle
This product has met the following criteria to qualify for the following awards: